98 related articles for article (PubMed ID: 12484066)
1. [A patient with diffuse peritoneal metastases of GIST who was administered STI571].
Mukaide H; Hasuike Y; Takeda Y; Shin E; Mishima H; Nishisyou I; Tujinaka T; Kawahara K; Kurata A
Gan To Kagaku Ryoho; 2002 Nov; 29(12):2329-32. PubMed ID: 12484066
[TBL] [Abstract][Full Text] [Related]
2. [A case of metastatic gastrointestinal stromal tumor developing a resistance to STI571 (imatinib mesylate)].
Miyake M; Takeda Y; Hasuike Y; Kashiwazaki M; Mishima H; Ikenaga M; Mano M; Takada Y; Hirota S; Tsujinaka T
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1791-4. PubMed ID: 15553717
[TBL] [Abstract][Full Text] [Related]
3. Treatment with STI571, a tyrosine kinase inhibitor, for gastrointestinal stromal tumor with peritoneal dissemination and multiple liver metastases.
Yamamoto S; Kubo S; Shuto T; Yamamoto T; Hirohashi K; Tanaka H; Takemura S; Kanazawa A; Kinoshita H
J Gastroenterol; 2003; 38(9):896-9. PubMed ID: 14564636
[TBL] [Abstract][Full Text] [Related]
4. [A patient with metastatic gastrointestinal stromal tumor who responded to STI571].
Terashima M; Abe K; Takeda Y; Saito K; Uesugi N; Kato K; Sato K; Maekawa T
Gan To Kagaku Ryoho; 2002 Apr; 29(4):607-10. PubMed ID: 11977548
[TBL] [Abstract][Full Text] [Related]
5. [Successful treatment of huge peritoneal metastasis from duodenal gastrointestinal stromal tumor resistant for imatinib mesylate].
Sakakura C; Kumano T; Mizuta Y; Yamaoka N; Sagara Y; Hagiwara A; Otsuji E
Gan To Kagaku Ryoho; 2007 Nov; 34(12):2144-6. PubMed ID: 18219926
[TBL] [Abstract][Full Text] [Related]
6. Effect of imatinib (STI571) on metastatic gastrointestinal stromal tumors: report of a case.
Ando Y; Tsunoda T; Beck Y; Takayama T; Tahara H
Surg Today; 2005; 35(2):157-60. PubMed ID: 15674500
[TBL] [Abstract][Full Text] [Related]
7. Impact of surgery on advanced gastrointestinal stromal tumors (GIST) in the imatinib era.
Bonvalot S; Eldweny H; Péchoux CL; Vanel D; Terrier P; Cavalcanti A; Robert C; Lassau N; Cesne AL
Ann Surg Oncol; 2006 Dec; 13(12):1596-603. PubMed ID: 16957966
[TBL] [Abstract][Full Text] [Related]
8. [Peritoneal dissemination from gastrointestinal stromal tumor of small intestine responding completely to imatinib mesylate (STI 571)].
Yamanaka H; Mizushima T; Mikata S; Ito T; Nonaka K; Ide H; Michiura T; Kainuma S; Iwase K
Gan To Kagaku Ryoho; 2005 Dec; 32(13):2125-8. PubMed ID: 16352942
[TBL] [Abstract][Full Text] [Related]
9. A successful case of oral molecularly targeted therapy with imatinib for peritoneal metastasis of a gastrointestinal stromal tumor.
Kanda T; Ohashi M; Makino S; Kaneko K; Matsuki A; Nakagawa S; Hatakeyama K
Int J Clin Oncol; 2003 Jun; 8(3):180-3. PubMed ID: 12851843
[TBL] [Abstract][Full Text] [Related]
10. Effect of a tyrosine kinase inhibitor STI571 in a patient with hepatic metastases from a duodenal gastrointestinal stromal tumor.
Sawaki A; Ohashi K; Yamao K; Inada K; Shimizu Y; Matsuura A; Nakamura T; Suzuki T; Hara K; Okubo K; Ohno R
J Gastroenterol; 2003; 38(7):690-4. PubMed ID: 12898363
[TBL] [Abstract][Full Text] [Related]
11. [Metastatic gastrointestinal stromal tumors responded to the treatment with STI571 after polysurgery for recurrent lesions--report of two cases].
Sasaki K; Doi T; Matsumoto G; Tsuruta K; Okamoto A; Funada N
Gan To Kagaku Ryoho; 2003 Jul; 30(7):1021-5. PubMed ID: 12894723
[TBL] [Abstract][Full Text] [Related]
12. [Two cases of postoperative recurrence of gastric GIST treated by imatinib].
Kikuchi H; Konn H; Kamiya K; Baba M; Ohta M; Kondo K; Hiramatsu Y; Yamamoto M; Tanaka T; Sugimura H; Ohashi M; Kanda T; Nakamura S
Gan To Kagaku Ryoho; 2004 Oct; 31(10):1569-73. PubMed ID: 15508453
[TBL] [Abstract][Full Text] [Related]
13. [New orientations in the management of advanced, metastatic gastrointestinal stromal tumors (GIST): combination of surgery and systemic therapy with imatinib in a case of primary gastric location].
Catani M; De Milito R; Simi M
Chir Ital; 2005; 57(1):127-33. PubMed ID: 15832750
[TBL] [Abstract][Full Text] [Related]
14. Outcome of metastatic GIST in the era before tyrosine kinase inhibitors.
Gold JS; van der Zwan SM; Gönen M; Maki RG; Singer S; Brennan MF; Antonescu CR; De Matteo RP
Ann Surg Oncol; 2007 Jan; 14(1):134-42. PubMed ID: 17080234
[TBL] [Abstract][Full Text] [Related]
15. Surgical resection of gastrointestinal stromal tumors after treatment with imatinib.
Andtbacka RH; Ng CS; Scaife CL; Cormier JN; Hunt KK; Pisters PW; Pollock RE; Benjamin RS; Burgess MA; Chen LL; Trent J; Patel SR; Raymond K; Feig BW
Ann Surg Oncol; 2007 Jan; 14(1):14-24. PubMed ID: 17072676
[TBL] [Abstract][Full Text] [Related]
16. [Tyrosine kinase inhibitor as a targeted therapy for GIST tumors].
Joensuu H
Duodecim; 2002; 118(22):2305-12. PubMed ID: 12523107
[No Abstract] [Full Text] [Related]
17. A pilot study of imatinib mesylate (STI571) on gastrointestinal stromal tumors in Japanese patients.
Sawaki A; Yamao K; Nakamura T; Suzuki T; Okubo K; Hara K; Kawai H; Yamamura Y; Ito S; Mochiduki Y; Ohno R
J Gastroenterol; 2004; 39(4):329-33. PubMed ID: 15168243
[TBL] [Abstract][Full Text] [Related]
18. [A long-term survival case with multiple liver metastases from duodenal gastrointestinal stromal tumor that was drastically reduced by the treatment with imatinib].
Sakakura C; Miyagawa K; Fukuda K; Kin S; Nakase Y; Kuriu Y; Nakashima S; Yoshikawa T; Yamaoka N; Sagara Y; Hagiwara A; Yamagishi H
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1739-41. PubMed ID: 16315926
[TBL] [Abstract][Full Text] [Related]
19. Cystic changes in hepatic and peritoneal metastases from gastrointestinal stromal tumors treated with Gleevec.
Bechtold RE; Chen MY; Stanton CA; Savage PD; Levine EA
Abdom Imaging; 2003; 28(6):808-14. PubMed ID: 14753595
[TBL] [Abstract][Full Text] [Related]
20. Surgery and imatinib in the management of GIST: emerging approaches to adjuvant and neoadjuvant therapy.
Eisenberg BL; Judson I
Ann Surg Oncol; 2004 May; 11(5):465-75. PubMed ID: 15123459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]